Cerus (CERS) Capital Expenditures Growth (3y) (2013 - 2026)
Cerus (CERS) Capital Expenditures Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 10.17% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 1.81% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 10.35% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.15% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 0.84% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 8.08% |
| 10 | Cerus | 496.03 Mn | 416.34 Mn | 27.89 Mn | -46.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -46.53% |
| Dec 31, 2025 | 1.91% |
| Sep 30, 2025 | 47.26% |
| Jun 30, 2025 | 82.87% |
| Mar 31, 2025 | -0.30% |
| Dec 31, 2024 | 28.13% |
| Sep 30, 2024 | 48.31% |
| Jun 30, 2024 | 8.61% |
| Mar 31, 2024 | 78.57% |
| Dec 31, 2023 | -26.26% |
| Sep 30, 2023 | 121.64% |
| Jun 30, 2023 | -0.81% |
| Mar 31, 2023 | 49.95% |
| Dec 31, 2022 | 37.51% |
| Sep 30, 2022 | -33.41% |
| Jun 30, 2022 | -71.01% |
| Mar 31, 2022 | -67.58% |
| Dec 31, 2021 | -3.73% |
| Sep 30, 2021 | -22.73% |
| Jun 30, 2021 | -29.93% |